MedTrace Logo

Assessing the Engagement of Transgender and Other Gender Minority Youth Across the HIV Continuum of Care

NCT02449629 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 187

Last updated 2017-02-28

No results posted yet for this study

Summary

This study uses a transformative multiphasic mixed-methods research design that incorporates elements of the following designs:

* Sequential: a secondary data analysis was conducted, using data from ATN 039, ATN 086, and ATN 106, to influence the development of the qualitative interview and quantitative survey instruments for primary data collection.
* Convergent parallel: concurrent collection and analysis of both qualitative and quantitative primary data that will be combined to address the study objectives.

Conditions

  • Transgender, HIV Continuum of Care

Sponsors & Collaborators

  • National Institute on Drug Abuse (NIDA)

    collaborator NIH

  • National Institute of Mental Health (NIMH)

    collaborator NIH

  • University of North Carolina, Chapel Hill

    lead OTHER

Principal Investigators

  • Gary Harper, PhD · University of Michigan

Eligibility

Min Age
16 Years
Max Age
24 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-06-30
Primary Completion
2016-01-31
Completion
2016-01-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02449629 on ClinicalTrials.gov